Johnson & Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD

The FDA's Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements.

At a Tuesday meeting with the FDA's public advisory committee, the panel focused on “challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity, utilizing cannabinoids as a case study.”